Detalhe da pesquisa
1.
Prevalence of hearing screening failures in low-risk childhood cancer survivors.
Pediatr Blood Cancer
; 69(2): e29437, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34854541
2.
Prevalence of Ototoxicity Following Hematopoietic Stem Cell Transplantation in Pediatric Patients.
Biol Blood Marrow Transplant
; 26(1): 107-113, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31494228
3.
Patient and Parent Decision-Making in the Setting of Chemotherapy-Induced Sensorineural Hearing Loss.
Ear Hear
; 41(6): 1684-1691, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-33136642
4.
Prevalence and nature of hearing loss in a cohort of children with sickle cell disease.
Pediatr Blood Cancer
; 66(1): e27457, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30207054
5.
Asymmetric sensorineural hearing loss is a risk factor for late-onset hearing loss in pediatric cancer survivors following cisplatin treatment.
Pediatr Blood Cancer
; 66(1): e27494, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30334605
6.
Determining the prevalence of vestibular screening failures in pediatric cancer patients whose therapies include radiation to the head/neck and platin-based therapies: A pilot study.
Pediatr Blood Cancer
; 65(6): e26992, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29380538
7.
Scope of hearing loss in Beckwith-Wiedemann syndrome and hemihypertrophy.
Am J Med Genet A
; 179(11): 2307-2310, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31339626
8.
Children with non-central nervous system tumors treated with platinum-based chemotherapy are at risk for hearing loss and cognitive impairments.
Front Pediatr
; 12: 1341762, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38571700
9.
Assessing quality of life in childhood cancer survivors at risk for hearing loss: a comparison of HEAR-QL and PROMIS measures.
Front Oncol
; 14: 1362315, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38511136
10.
Auditory complications in childhood cancer survivors: a report from the childhood cancer survivor study.
Pediatr Blood Cancer
; 57(1): 126-34, 2011 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-21328523
11.
Cisplatin Ototoxicity: Examination of the Impact of Dosing, Infusion Times, and Schedules In Pediatric Cancer Patients.
Front Oncol
; 11: 673080, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34262862
12.
Late onset hearing loss: a significant complication of cancer survivors treated with Cisplatin containing chemotherapy regimens.
J Pediatr Hematol Oncol
; 32(2): 119-23, 2010 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-20098336
13.
Physician Support for Non-Physician Advanced Practice Providers for Persons With Cardiopulmonary Disease.
Respir Care
; 65(11): 1702-1711, 2020 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-32606076
14.
Encouraging physicians to screen for and intervene in substance use disorders: obstacles and strategies for change.
J Addict Dis
; 27(3): 77-97, 2008.
Artigo
Inglês
| MEDLINE | ID: mdl-18956531
15.
Sustaining Screening, Brief Intervention and Referral to Treatment (SBIRT) services in health-care settings.
Addiction
; 112 Suppl 2: 92-100, 2017 02.
Artigo
Inglês
| MEDLINE | ID: mdl-28074565
16.
Screening, Brief Intervention and Referral to Treatment (SBIRT): rationale, program overview and cross-site evaluation.
Addiction
; 112 Suppl 2: 3-11, 2017 02.
Artigo
Inglês
| MEDLINE | ID: mdl-28074566
17.
Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance.
J Addict Med
; 11(3): 178-190, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28406856
18.
A national study of the substance abuse treatment workforce.
J Subst Abuse Treat
; 24(1): 51-7, 2003 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-12646330
19.
Hearing loss in pediatric oncology patients receiving carboplatin-containing regimens.
J Pediatr Hematol Oncol
; 30(2): 130-4, 2008 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-18376265
20.
Teaching about Substance Abuse.
Virtual Mentor
; 10(1): 21-9, 2008 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-23206739